Here are three things to know.
1. President Trump’s list of imports that may be hit with the increased tariffs include ingredients used to produce insulin, epinephrine and antidepressants.
2. According to the FDA, China is one of the largest suppliers of ingredients for domestic prescription drug manufacturers.
3. “We are concerned that the proposed tariffs may lead to increased costs of manufacturing for generics and biosimilars and thus higher prescription drug prices for patients in the U.S.,” the Association for Accessible Medicines said in a statement.
More articles on business:
AI with an ROI — why natural language processing makes sense for healthcare
The future of the connected clinician
Amazon’s ad business could hit $20B threshold in 2020
